Drug Shortage Report for ALPROLIX
Report ID | 192507 |
Drug Identification Number | 02422956 |
Brand name | ALPROLIX |
Common or Proper name | ALPROLIX |
Company Name | SANOFI-AVENTIS CANADA INC |
Market Status | MARKETED |
Active Ingredient(s) | RECOMBINANT HUMAN COAGULATION FACTOR IX, FC FUSION PROTEIN |
Strength(s) | 3000UNIT |
Dosage form(s) | POWDER FOR SOLUTION KIT |
Route of administration | INTRAVENOUS INTRAVENOUS |
Packaging size | 1 |
ATC code | B02BD |
ATC description | VITAMIN K AND OTHER HEMOSTATICS |
Reason for shortage | Other (Please describe in comments) |
Anticipated start date | |
Actual start date | 2023-05-15 |
Estimated end date | 2023-06-20 |
Actual end date | 2023-06-20 |
Shortage status | Resolved |
Updated date | 2023-06-21 |
Company comments | Reason for the shortage- Overselling |
Health Canada comments | |
Tier 3 Status | No |
Company contact information | email: CAINTERNET@sanofi.com Telephone: 1-800-265-7927 |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v13 | 2023-06-21 | English | Compare |
v12 | 2023-06-20 | French | Compare |
v11 | 2023-06-20 | English | Compare |
v10 | 2023-06-20 | French | Compare |
v9 | 2023-06-20 | English | Compare |
v8 | 2023-06-14 | French | Compare |
v7 | 2023-06-14 | English | Compare |
v6 | 2023-06-05 | French | Compare |
v5 | 2023-06-05 | English | Compare |
v4 | 2023-05-16 | English | Compare |
v3 | 2023-05-15 | French | Compare |
v2 | 2023-05-15 | English | Compare |
v1 | 2023-05-15 | English | Compare |
Showing 1 to 13 of 13